Yassine Houbachi discusses his strategy for leading Moroccan generics player Polymedic, the market environment in Morocco, and what future challenges may be. In addition, Houbachi introduces RIM Pharma, an innovative young company which is expanding access to oncology diagnostics in Morocco.
The market being stagnant, prices are dropping and competition is rising. It is, therefore, crucial to define the right growth channel, such as exports, as Morocco is positioning itself as a hub for the region
